Ondansetrom Tolife (Ondansetron)

Ondansetron, the active ingredient in Ondansetrom Tolice, is a serotonin 5‑HT3 receptor antagonist presented as a tablet for oral use. It is used to prevent nausea and vomiting caused by chemotherapy, radiation therapy, and surgery in adult and pediatric patients.

GNH USA supplies Ondansetrom Tolice as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

Ondansetron is employed across several therapeutic areas to control nausea and vomiting. - Chemotherapy‑induced nausea and vomiting (CINV): helps reduce the frequency and severity of nausea and vomiting associated with cancer chemotherapy. - Radiation‑induced nausea and vomiting (RINV): provides relief from nausea and vomiting that occur during or after radiation treatment. - Post‑operative nausea and vomiting (PONV): reduces the incidence of nausea and vomiting following surgical procedures.

Side effects reported with ondansetron are generally mild to moderate and vary in frequency.

Common Side Effects: - Headache: mild to moderate intensity. - Constipation: reduced bowel movements. - Diarrhoea: loose stools. - Fatigue: feeling of tiredness. - Dizziness: light‑headed sensation.

Serious or Rare Side Effects: - QT interval prolongation: cardiac rhythm changes that may lead to arrhythmia. - Severe allergic reaction: rash, itching, swelling, or difficulty breathing. - Serotonin syndrome: agitation, hyperreflexia, rapid heart rate, and high temperature when combined with other serotonergic agents. - Hepatic dysfunction: elevated liver enzymes indicating liver stress. - Vision changes: blurred vision or transient visual disturbances.

When using ondansetron, certain precautions should be observed to ensure safe and effective therapy. - Cardiac monitoring: patients with known prolonged QT interval or electrolyte abnormalities should be monitored. - Electrolyte balance: correct potassium, magnesium, and calcium levels before initiating therapy. - Pregnancy: use only if the potential benefit justifies the potential risk to the fetus. - Breastfeeding: weigh the benefits against possible infant exposure through milk. - Drug interactions: review concomitant medications for potential serotonergic or QT‑prolonging effects. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Ondansetron may interact with several medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Apomorphine: concurrent use can cause profound hypotension and loss of consciousness. - Certain anti‑arrhythmic drugs (e.g., amiodarone, quinidine): may increase the risk of QT prolongation.

Moderate Interactions (Monitor Closely): - Other serotonergic agents (e.g., SSRIs, SNRIs, triptans): may raise the risk of serotonin syndrome. - CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): can increase ondansetron plasma levels. - CYP2D6 inhibitors (strong) (e.g., fluoxetine, paroxetine): may raise plasma concentrations. - Diuretics that cause electrolyte loss: may exacerbate QT‑related risks.